INTRODUCTION
The lung is the essential organ for respiration. Because the lung mucosal area contacts air for gas exchange, it can be infected easily by various microbes, such as influenza, respiratory syncytial virus (RSV), pneumococcus, and Aspergillus. Nevertheless, the lung possesses a sentinel system that identifies these threats and elicits an anti-microbial response. In this review, we focus on the immune response to respiratory viral infection, which can induce acute respiratory disease.
Dendritic cells (DCs) participate in the first line of defense in the innate immune response against respiratory viral infection. DCs are distributed throughout the entire lung, with each subset localized to a specific compartment of the organ (1) . In the absence of inflammation, lung DCs can be subdivided into three distinct subsets based on the combined expression of cell surface markers: CD103 ＋ conventional DCs (cDCs), CD11b ＋ cDCs, and plasmacytoid DCs (pDCs). During inflammation, monocyte-derived DCs (moDCs) are generated ＋ cDCs, CD11b ＋ cDCs, CD8α ＋ cDCs, and pDCs. CD103
＋ cDCs are mainly located in mucosal walls, and extend their process to alveolar space for capture viral antigen. CD11b ＋ cDCs are distributed in lamina propria, which is below the basement membrane. pDCs are place in conducting airway, parenchyma and alveolar septa. After viral infection, inflammatory lung was induced the recruitment of moDCs. And viral antigen uptake migratory DCs translocate to draining mediastinal lymph nodes via afferent lymphatics. Migrated DCs can present to naïve T cells. Lymph node resident CD8α
＋ DCs can receive antigen from migratory DCs, and present T cells.
in the lung (2,3) (Table I) .
In a respiratory virus infection, one virus can induce different types of immune responses depending on the type of DC subset activated (4, 5) . In this process, cell type-specific pattern recognition receptors (PRRs) may also be involved (6) . Each DC subset expresses different pattern recognition receptors, thereby enabling the cells to react differently depending on the type of virus infection (7) . In particular, neither a vaccine nor an effective antiviral therapy is currently available against RSV infection (8). To development vaccine for RSV infection, understanding the role of the lung DC subsets is important. Determining the specialized functions of the various lung DC subsets is challenging. This review focuses on the distinctive features and antiviral functions exhibited by the various lung DC subsets during respiratory virus infection in mice.
CD103
＋ conventional dendritic cells 
CD11b
＋ conventional dendritic cells
In the lung, CD11b ＋ cDCs reside mainly in the lamina propria, which is located below the basement membrane (Fig. 1 ). CD11b ＋ cDCs are heterogeneous and their development depends on both Flt3 and M-CSFR (11). Dependency on M-CSFR is suggestive of a monocytic origin, and some non-lymphoid CD11b ＋ cDCs can be reconstituted by pre-DC.
＋ cDCs frequently lack CD103 but express CD11b.
Despite this, markers to distinguish the two ontogenically distinct subsets differ between tissues. For instance, expression of CD64 (FcγRI) helps distinguish between these two subpopulations in muscle, whereas expression of CD103 helps discriminate between the two CD11b ＋ DC subsets in the intestinal lamina propria (40, 41 Plasmacytoid dendritic cells pDCs are distributed to conducting airways as well as parenchyma and alveolar septa in the lung (Fig. 1) . These cells represent a small subset of DCs, which share a common origin with cDCs. pDCs develop in the bone marrow from a continuum of Flt3 ＋ c-Kit low progenitors, including lymphoid progenitors and common DC progenitors (CDPs). Their development proceeds through the putative committed pDC progenitor and immature pDCs in the bone marrow toward the mature peripheral pDCs (55) . Upregulation of the basic helix-loop-helix transcription factor (E protein) E2-2 serves as a key lineage commitment event in pDC development (56, 57) . Because E proteins are essential regulators of lymphocyte development, E2-2 activity may underlie the distinct lymphoid features of pDCs. These cells express low levels of MHC class II and costimulatory molecules, as well as low levels of CD11c in the steady state (16) . They also express a narrow range of PRRs, including TLR7 and TLR9. Generally, pDCs function during the antiviral response to produce type I IFNs that induce the adaptive immune response. Some studies have shown that pDCs can trigger an influenza-specific CD8 ＋ T cell response in vitro (58-60).
However, RSV-stimulated pDCs cannot enhance the proliferation and maturation of antigen-specific T cells, but rather promote direct antiviral activity by secreting type I IFNs (61 (22) . Instead, pDC depletion led to a reduction in antiviral antibody production after clearance of influenza from the lung. However, depletion of pDCs resulted in decreases viral clearance of RSV infection and exacerbation of all facets of immune-mediated pathology, including increase of airway hyper-responsiveness, pulmonary inflammation, and mucus production (62, 63) . In Ikaros L/L mice, expressing low levels of the transcription factor Ikaros (Ik(L/L)) lack peripheral pDCs, pDCs regulate T cell accumulation in the bronchoalveolar space during early influenza virus infection, but are not essential for controlling this disease (64) . These data demonstrated that the antiviral CD8 ＋ T cell response was independent of pDCs. However, in BDCA2-DTR mice, pDC depletion reduced early type I IFN production, enhanced early viral replication, and impaired the survival and accumulation of virus-specific cytotoxic T lymphocytes in systemic MCMV or VSV infection (65) . According to a recent report, pDCs do not appear to influence viral burden, survival, or virus-specific CD8 ＋ T cell response during local HSV infection. In contrast, pDCs were important for early type I IFN production, NK cell activation, and CD8 ＋ T cell response during systemic HSV infection (66) . These results help elucidate the antiviral role of pDCs in respiratory virus infection. However, whether pDCs can differentially respond under different conditions between host and virus remains to be determined.
Monocyte-derived dendritic cells
Inflammatory moDCs differentiate from circulating Ly6C hi monocytes (67) (Fig. 1) . Recent studies have established that, under conditions of stress, such as TLR stimulation, early hematopoietic precursors can differentiate into DCs, bypassing normal growth and differentiation requirements (68, 69) . However, the contribution of monocytes and DC-related precursors to the differentiation of lung moDCs in response to respiratory virus infection remains unclear. Most inflammatory DCs are characterized by the expression of Ly6C, CD11b, MHC class II, and intermediate levels of CD11c (67) . Ly6C is a distinct marker of monocytes, but that is downregulated rapidly in the presence of moDCs (42, 70, 71) . Therefore, distinguishing inflammatory moDCs from nonlymphoid CD11b ＋ DCs is challenging. As mentioned in the preceding section, one report demonstrated that staining with the MAR-1 antibody directed against the high affinity immunoglobulin E (IgE) α chain receptor (FcεRI) is better than staining for Ly6C (2) . A recent study showed that inflammatory moDCs are recruited to draining lymph nodes following lipopolysaccharide (LPS) stimulation, and that these moDCs express the lectin DC-SIGN/CD209, the mannose receptor CD206, and CD14 (71). Monocytes were originally considered the immediate upstream precursors of cDCs. This hypothesis originated from studies showing that DCs could be differentiated in vitro from human blood mononuclear cells using GM-CSF and IL-4 (72). When monocytes were transferred into mice with an inflammatory milieu dependent on GM-CSF, monocytes produced a distinct type of splenic DC (73) . Nowadays, the concept that monocytes are a precursor of inflammatory DCs is widely accepted. More recent studies have shown that monocytes contribute to cDC development in the steady state (41, (74) (75) (76) . However, because this review focuses on DC subsets that act against respiratory virus infection, we refer to mononuclear cell-derived DCs as moDCs in inflammation.
CD11b ＋ DCs can produce TNF and iNOS-derived NO during L. monocytogenes infection. These Tip-DCs are dependent on CCR2 and mediate innate immunity against this intracellular bacterial pathogen (77) , suggesting that Tip-DCs may contribute to the elimination of intracellular pathogens. A recent study identified an uncharacterized zinc finger transcription factor named zDC (Zbtb46, Btbd4) that is expressed specifically by cDCs and committed cDC precursors but not by monocytes, pDCs, or other immune cell populations (78, 79) . zDC-DTR mice treated with diphtheria toxin eliminated LPS-induced inflammatory moDCs, suggesting that LPS induced inflammatory moDCs that belong to a real DC population. However, L. monocytogenes infection-induced Tip-DCs were not ablated by DT treatment in these mice. Given this result, Tip-DCs most likely resemble monocytes more than DCs. CD11b ＋ moDCs are recruited to inflammatory sites in the lungs following exposure to respiratory antigen or virus. During influenza infection, moDCs also differentiate from monocytes in the lung. These trafficking and differentiation process are dependent on type I IFN signaling and CCR2 during influenza infection (80, 81) . Some in vitro studies suggested that type I IFN-producing moDCs can regulate viral replication (82, 83) ; however, whether moDCs participate directly in the antiviral response remains unclear. Interestingly, CCR2-deficient mice did not exhibit increased influenza viral titer.
Whether moDCs can migrate to draining lymph nodes and induce the T cell response has not been determined (45, 46 
